← Leaderboards
David Feldman
Stanford University
$8,560,053
Attributed
$8,560,053
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $971.1K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$8,560,053 · 7
By mechanism
R01$5,274,208 · 3
T32$2,900,451 · 1
M01$269,954 · 2
R56$115,440 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Michael L Cleary$25,231,473
- Helen M Blau$36,149,136
- Melissa L Bondy$46,044,245
- Yunyan Jennifer Jennifer Zhang$7,749,335
Others in their field
Top investigators on “Prostate Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Charles A Coltman · Southwest Oncology Group$165,272,744
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$60,981,384
- William J. Blot · Vanderbilt University$59,429,890
- Richard L Schilsky · University Of Chicago$55,185,062
Research focus
Prostate NeoplasmsOsteoporosisVitamin DHuman SubjectClinical ResearchPharmaceutical PreparationsMolecularPathway InteractionsHormone Regulation /Control MechanismGenesLightMalignant NeoplasmsCellsMediatingCalcitriolDiabetes MellitusClinical TrialsEndocrinology1,25 DihydroxycholecalciferolClinical TreatmentGrantHormonalInvestigationRegulation
Grant awards (41)
The Development of Vitamin D as a Therapy for Breast Cancer$286,213
R01 · FY2011 · CA · contact PI
Diabetes, Endocrinology and Metabolism$186,403
T32 · FY2011 · DK · contact PI
Diabetes, Endocrinology and Metabolism$51,134
T32 · FY2011 · DK · contact PI
The Development of Vitamin D as a Therapy for Breast Cancer$295,065
R01 · FY2010 · CA · contact PI
Diabetes, Endocrinology and Metabolism$149,582
T32 · FY2010 · DK · contact PI
Diabetes, Endocrinology and Metabolism$55,592
T32 · FY2010 · DK · contact PI
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$49,198
R01 · FY2010 · DK · contact PI
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$381,197
R01 · FY2009 · DK · contact PI
The Development of Vitamin D as a Therapy for Breast Cancer$295,065
R01 · FY2009 · CA · contact PI
Diabetes, Endocrinology and Metabolism$234,809
T32 · FY2009 · DK · contact PI
Diabetes, Endocrinology and Metabolism$52,067
T32 · FY2009 · DK · contact PI
The Development of Vitamin D as a Therapy for Breast Cancer$8,000
R01 · FY2009 · CA · contact PI
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$370,094
R01 · FY2008 · DK · contact PI
The Development of Vitamin D as a Therapy for Breast Cancer$295,065
R01 · FY2008 · CA · contact PI
Diabetes, Endocrinology and Metabolism$215,593
T32 · FY2008 · DK · contact PI
Diabetes, Endocrinology and Metabolism$49,514
T32 · FY2008 · DK · contact PI
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$366,650
R01 · FY2007 · DK · contact PI
Diabetes, Endocrinology and Metabolism$181,348
T32 · FY2007 · DK · contact PI
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$366,600
R01 · FY2006 · DK · contact PI
Diabetes, Endocrinology and Metabolism$283,952
T32 · FY2006 · DK · contact PI
Diabetes, Endocrinology and Metabolism$238,881
T32 · FY2005 · DK
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$115,440
R56 · FY2005 · DK
Androgen-Independent Prostate Cancer: Mechanisms &Treat$349,914
R01 · FY2004 · CA
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$337,387
R01 · FY2004 · DK
Diabetes, Endocrinology and Metabolism$293,446
T32 · FY2004 · DK
Androgen-Independent Prostate Cancer: Mechanisms &Treat$349,891
R01 · FY2003 · CA
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$327,560
R01 · FY2003 · DK
Diabetes, Endocrinology and Metabolism$288,714
T32 · FY2003 · DK
Androgen-Independent Prostate Cancer: Mechanisms &Treat$337,187
R01 · FY2002 · CA
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$318,019
R01 · FY2002 · DK
Diabetes, Endocrinology and Metabolism$263,807
T32 · FY2002 · DK
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$297,547
R01 · FY2001 · DK
DIABETES, ENDOCRINOLOGY AND METABOLISM$244,484
T32 · FY2001 · DK
VITAMIN D TREATMENT OF PROSTATE CANCER$134,676
M01 · FY2001 · RR
SAFETY OF EB1089 IN EARLY RECURRENT PROSTATE CANCER$134,676
M01 · FY2001 · RR
VITAMIN D TREATMENT OF PROSTATE CANCER$0
M01 · FY2001 · RR
SAFETY OF EB1089 IN EARLY RECURRENT PROSTATE CANCER$0
M01 · FY2001 · RR
VITAMIN D RECEPTOR AND REGULATION OF HORMONE RESPONSE$243,556
R01 · FY2000 · DK
DIABETES, ENDOCRINOLOGY AND METABOLISM$111,125
T32 · FY2000 · DK
VITAMIN D TREATMENT OF PROSTATE CANCER$602
M01 · FY2000 · RR
SAFETY OF EB1089 IN EARLY RECURRENT PROSTATE CANCER$0
M01 · FY2000 · RR